HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
Active, not recruiting
University of Zimbabwe
This study is being done to understand if using birth control causes changes in the immune
cells within the reproductive tract of healthy women. Immune cells are important because
they help prevent infections from starting and help fight infections that have started.
Immune cells are also the type of cells that HIV (human immunodeficiency virus) infects so
understanding more about them will help to better understand how to prevent the spread of
Immune cells will be studied from the reproductive tract of women who want to start using
one of the following contraceptives: Depo-Provera (DMPA), NET-EN, MPA/E2 (Cyclofem®), the
levonorgestrel subdermal implant (Jadelle® ), the etonogestrel subdermal implant (Implanon®
or Nexplanon® ) and the copper IUD.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.